Piscataway, NJ, December 27, 2024 –Camber Pharmaceuticals is excited to announce the addition of Dicyclomine Hydrochloride Capsules, USP.
Dicyclomine Hydrochloride Capsules, USP are an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome.
Dicyclomine Hydrochloride Capsules, USP are available in 10 mg strength, packaged in 100 and 1000 count bottles.
To find out more information on Dicyclomine Hydrochloride Capsules, USP please visit: www.camberpharma.com/dicyclominecapsules
